246 related articles for article (PubMed ID: 12025912)
1. Oxerutins (Venoruton): efficacy in chronic venous insufficiency--a double-blind, randomized, controlled study.
Petruzzellis V; Troccoli T; Candiani C; Guarisco R; Lospalluti M; Belcaro G; Dugall M
Angiology; 2002; 53(3):257-63. PubMed ID: 12025912
[TBL] [Abstract][Full Text] [Related]
2. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Di Renzo A; Ruffini I; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cornelli U; Hosoi M; Cacchio M
Angiology; 2006; 57(2):131-8. PubMed ID: 16518519
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the efficacy of oxerutins compared to placebo in patients with chronic venous insufficiency treated with compression stockings.
Unkauf M; Rehn D; Klinger J; de la Motte S; Grossmann K
Arzneimittelforschung; 1996 May; 46(5):478-82. PubMed ID: 8737630
[TBL] [Abstract][Full Text] [Related]
4. Comparison between the efficacy and tolerability of oxerutins and troxerutin in the treatment of patients with chronic venous insufficiency.
Rehn D; Golden G; Nocker W; Diebschlag W; Lehmacher W
Arzneimittelforschung; 1993 Oct; 43(10):1060-3. PubMed ID: 8267669
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial.
Kiesewetter H; Koscielny J; Kalus U; Vix JM; Peil H; Petrini O; van Toor BS; de Mey C
Arzneimittelforschung; 2000 Feb; 50(2):109-17. PubMed ID: 10719612
[TBL] [Abstract][Full Text] [Related]
6. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency.
Rehn D; Unkauf M; Klein P; Jost V; Lücker PW
Arzneimittelforschung; 1996 May; 46(5):483-7. PubMed ID: 8737631
[TBL] [Abstract][Full Text] [Related]
7. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial.
Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Griffin M; Ippolito E; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S21-4. PubMed ID: 12011969
[TBL] [Abstract][Full Text] [Related]
8. Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study.
Ippolito E; Belcaro G; Dugall M; Cesarone MR; Feragalli B; Errichi BM; Gizzi G; Pellegrini L; Ledda A; Luzzi R; Ricci A; Bavera P; Hosoi M; Corsi M; Errichi S
Panminerva Med; 2011 Sep; 53(3 Suppl 1):13-9. PubMed ID: 22108472
[TBL] [Abstract][Full Text] [Related]
9. HR, 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Stuard S; Corsi M
Angiology; 2005; 56(2):165-72. PubMed ID: 15793606
[TBL] [Abstract][Full Text] [Related]
10. HR, 0-(beta-hydroxyethyl)-rutosides, in comparison with diosmin+hesperidin in chronic venous insufficiency and venous microangiopathy: an independent, prospective, comparative registry study.
Cesarone MR; Belcaro G; Pellegrini L; Ledda A; Di Renzo A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M
Angiology; 2005; 56(1):1-8. PubMed ID: 15678250
[TBL] [Abstract][Full Text] [Related]
11. [Effect of 0-(beta-hydroxyethyl)-rutoside (Venoruton) on symptomatic venous insufficiency in the lower limbs].
Pedersen FM; Hamberg O; Sørensen MD; Neland K
Ugeskr Laeger; 1992 Sep; 154(38):2561-3. PubMed ID: 1413183
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of a red-vine-leaf extract in patients suffering from chronic venous insufficiency--results of a double-blind placebo-controlled study.
Rabe E; Stücker M; Esperester A; Schäfer E; Ottillinger B
Eur J Vasc Endovasc Surg; 2011 Apr; 41(4):540-7. PubMed ID: 21239190
[TBL] [Abstract][Full Text] [Related]
13. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
[TBL] [Abstract][Full Text] [Related]
14. Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids.
Jantet G
Angiology; 2002; 53(3):245-56. PubMed ID: 12025911
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a Butcher's broom preparation (Ruscus aculeatus L. extract) compared to placebo in patients suffering from chronic venous insufficiency.
Vanscheidt W; Jost V; Wolna P; Lücker PW; Müller A; Theurer C; Patz B; Grützner KI
Arzneimittelforschung; 2002; 52(4):243-50. PubMed ID: 12040966
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of O-(beta-hydroxyethyl)-rutosides at high dosage in counteracting the unwanted activity of oral contraceptives on venous function.
Cappelli R; Pecchi S; Oberhauser V; Forconi S; Di Perri T
Int J Clin Pharmacol Res; 1987; 7(4):291-9. PubMed ID: 3596872
[TBL] [Abstract][Full Text] [Related]
17. HR (Venoruton1000, Paroven, 0-[beta-hydroxyethyl]-rutosides) vs. Daflon 500 in chronic venous disease and microangiopathy: an independent prospective, controlled, randomized trial.
Belcaro G; Cesarone MR; Bavera P; Ricci A; Renton S; Leon M; Ippolito E; Dugall M; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jul; 7(3):139-45. PubMed ID: 12232562
[TBL] [Abstract][Full Text] [Related]
18. Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized trial.
Cesarone MR; Incandela L; DeSanctis MT; Belcaro G; Dugall M; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S25-8. PubMed ID: 12011970
[TBL] [Abstract][Full Text] [Related]
19. Oxerutins in the prevention of recurrence in chronic venous ulceration: randomized controlled trial.
Wright DD; Franks PJ; Blair SD; Backhouse CM; Moffatt C; McCollum CN
Br J Surg; 1991 Oct; 78(10):1269-70. PubMed ID: 1959004
[TBL] [Abstract][Full Text] [Related]
20. HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial.
Incandela L; Belcaro G; Renton S; DeSanctis MT; Cesarone MR; Bavera P; Ippolito E; Bucci M; Griffin M; Geroulakos G; Dugall M; Golden G; Acerbi G
J Cardiovasc Pharmacol Ther; 2002 Jan; 7 Suppl 1():S7-S10. PubMed ID: 12011966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
